Screener
Discontinued — last reported Q4 '25
CapEx at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Lexicon Pharmaceuticals’s 10-K, filed March 5, 2026.
- Filed
- Mar 5, 2026, 4:50 PM EST
- Fiscal year
- FY2025
- Accession
- 0001062822-26-000050
| Line item | Year Ended December 31, 2025 | Year Ended December 31, 2024 | Year Ended December 31, 2023 |
|---|---|---|---|
| (Decrease) increase in accounts payable and other liabilities | (30,222) | 14,801 | 6,454 |
| Net cash used in operating activities | (67,851) | (178,780) | (161,897) |
| Cash flows from investing activities: | |||
| Purchases of property and equipment | — | (1,031) | (470) |
| Purchases of investments | (139,838) | (328,747) | (223,343) |
| Maturities of investments | 252,858 | 314,400 | 173,870 |
| Net cash provided by (used in) investing activities | 113,020 | (15,378) | (49,943) |
| Cash flows from financing activities: |
Item 16. Form 10-K Summary
FAQ
- What is Lexicon Pharmaceuticals's capex?
- Lexicon Pharmaceuticals (LXRX) reported capex of $0 in Q4 2025.
- How has Lexicon Pharmaceuticals's capex changed year-over-year?
- Lexicon Pharmaceuticals's capex decreased by 100.0% year-over-year, from $474K to $0.
- What is the long-term trend for Lexicon Pharmaceuticals's capex?
- Over 3 years (2021 to 2024), Lexicon Pharmaceuticals's capex has grown at a -5.5% compound annual growth rate (CAGR), from $1.22M to $1.03M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Lexicon Pharmaceuticals's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude